The Institut du cancer de Montréal (ICM) is proud to have contributed to the implementation of a 3D printing park in the CRCHUM’s Technological Innovation and Development Laboratory (TID Lab) through a $300,000 investment.
“Thanks to a $300,000 grant from the Institute, matched by $300,000 from the Thoracic Surgery Research Foundation of Montreal, the TID Lab was able to acquire the latest technology in 3D printing. The high-tech 3D printers and scanners acquired through this grant are being used to develop prototypes of minimally invasive and endoscopic devices for the future of cancer treatment through patient’s natural orifices, without the need for painful surgery. This is the future of cancer therapeutics and the TID Laboratory in partnership with the ICM is leading the way!’’ – Dr. Moishe Liberman, Director – TID Lab
Dr. Bertrand Routy receives three prestigious awards
2 December 2021
Last October, Dr. Bertrand Routy won the 2021 Gairdner Early Career Investigator Award for his research linking the gut microbiota […]
The Institute joins forces with Uniprix
2 May 2022
The Institut du cancer de Montréal and the network of Uniprix-affiliated pharmacies have joined forces to support cancer research. This […]